Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression

por Wang, Feng, Zhang, Weihua, Wu, Tianfeng, Chu, Heying
Publicado 2018

Expression of concern: Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression

por Wang, Feng, Zhang, Weihua, Wu, Tianfeng, Chu, Heying
Publicado 2020

Retraction ‘Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression’

por Wang, Feng, Zhang, Weihua, Wu, Tianfeng, Chu, Heying
Publicado 2020

MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer

por Wang, Huaqi, Wang, Li, Zhang, Guojun, Lu, Chunya, Chu, Heying, Yang, Rui, Zhao, Guoqiang
Publicado 2017

Analysis of MAT3 gene expression in NSCLC

por Zheng, Shangen, Du, Yuwen, Chu, Heying, Chen, Xudong, Li, Ping, Wang, Yuanyuan, Ma, Yunyun, Wang, Huaqi, Zang, Wenqiao, Zhang, Guojun, Zhao, Guoqiang
Publicado 2013

Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migration

por Chu, Heying, Luo, Hailan, Wang, Huaqi, Chen, Xiaonan, Li, Ping, Bai, Yong, Zhang, Furui, Cheng, Ruirui, Chen, Shanshan, Wang, Yuanyuan, Zhao, Guoqiang, Zhang, Guojun
Publicado 2014

Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer

por Li, Ping, Li, Juan, Yang, Rui, Zhang, Furui, Wang, Huaqi, Chu, Heying, Lu, Yao, Dun, Shaozhi, Wang, Yuanyuan, Zang, Wenqiao, Du, Yuwen, Chen, Xiaonan, Zhao, Guoqiang, Zhang, Guojun
Publicado 2015